Survey of Testosterone Levels in Male Cancer Patients

Completed

Conditions studied: Hypogonadism

In brief

The purpose of this study is to survey the total serum testosterone levels in male patients with hormone-independent malignancies. The prevalence of hypogonadism is not known, but is thought to be significant. Results will be adjusted for age and stratified for type of cancer, stage, study site,and presence of opiate use for pain management, which is known to reduce testosterone levels.

Key facts

Study ID

NCT00483418

Run by

Beth Israel Medical Center

People needed

425

Starts

2007-06-01

Expected to finish

2009-12-01

Last updated by the study team

2011-03-11

Who can join

Age: 18 and older. Sex: male. Healthy volunteers: accepted.

You may qualify if…

• Age 18 or older
• Male Cancer patients coming to oncology appointments for treatment or follow-up
• Must be able to answer questionnaire in english, alone or with assistance
• Informed consent

You may not qualify if…

• Known HIV infection
• Known hypogonadism
• testosterone or DHEA supplementation within 3 months
• prostate, breast, or testicular cancer

Where it is running

• Beth Israel Medical Center — New York, New York, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.